Research Progress on the Relationship between Atherosclerosis and Inflammation - PubMed (original) (raw)

Review

Research Progress on the Relationship between Atherosclerosis and Inflammation

Yuhua Zhu et al. Biomolecules. 2018.

Abstract

Atherosclerosis is a chronic inflammatory disease; unstable atherosclerotic plaque rupture, vascular stenosis, or occlusion caused by platelet aggregation and thrombosis lead to acute cardiovascular disease. Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and adhesion molecules. This review discusses the effects of inflammation and the systemic inflammatory signaling pathway on atherosclerosis, the role of related signaling pathways in inflammation, the formation of atherosclerosis plaques, and the prospects of treating atherosclerosis by inhibiting inflammation.

Keywords: anti-inflammatory therapy; atherosclerosis; inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

• The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
  Spartalis M, Spartalis E, Tzatzaki E, Tsilimigras DI, Moris D, Kontogiannis C, Kaminiotis VV, Paschou SA, Chatzidou S, Siasos G, Voudris V, Iliopoulos DC. Spartalis M, et al. Cardiovasc Hematol Agents Med Chem. 2018;16(2):74-80. doi: 10.2174/1871525717666181211110332. Cardiovasc Hematol Agents Med Chem. 2018. PMID: 30526472 Review.
• Potential of anti-inflammatory agents for treatment of atherosclerosis.
  Chistiakov DA, Melnichenko AA, Grechko AV, Myasoedova VA, Orekhov AN. Chistiakov DA, et al. Exp Mol Pathol. 2018 Apr;104(2):114-124. doi: 10.1016/j.yexmp.2018.01.008. Epub 2018 Jan 31. Exp Mol Pathol. 2018. PMID: 29378168 Review.
• Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
  Maranhão RC, Leite AC Jr. Maranhão RC, et al. Curr Pharm Des. 2015;21(9):1196-204. doi: 10.2174/1381612820666141013150714. Curr Pharm Des. 2015. PMID: 25312729 Review.
• Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
  Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Hamilton JA, et al. Curr Atheroscler Rep. 2017 Nov 6;19(12):57. doi: 10.1007/s11883-017-0696-4. Curr Atheroscler Rep. 2017. PMID: 29110146 Review.
• Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.
  Yin QY, Zhao B, Qiu YY, Fei YX, Hu YH, Li YM. Yin QY, et al. J Cardiovasc Pharmacol. 2019 Nov;74(5):379-388. doi: 10.1097/FJC.0000000000000738. J Cardiovasc Pharmacol. 2019. PMID: 31730559 Review.

Cited by

• Roles and mechanisms of garlic and its extracts on atherosclerosis: A review.
  Li M, Yun W, Wang G, Li A, Gao J, He Q. Li M, et al. Front Pharmacol. 2022 Oct 3;13:954938. doi: 10.3389/fphar.2022.954938. eCollection 2022. Front Pharmacol. 2022. PMID: 36263122 Free PMC article. Review.
• Editorial: Pathophysiology, treatment and rehabilitation of atherosclerosis-related diseases in geriatric population.
  Xu Y, Zeng X, Tu WJ. Xu Y, et al. Front Med (Lausanne). 2024 Feb 8;11:1358769. doi: 10.3389/fmed.2024.1358769. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38390572 Free PMC article. No abstract available.
• CircRNA_0050486 promotes cell apoptosis and inflammation by targeting miR-1270 in atherosclerosis.
  Wang K, Bai X, Mei L, Miao Y, Jin F. Wang K, et al. Ann Transl Med. 2022 Aug;10(16):905. doi: 10.21037/atm-22-3745. Ann Transl Med. 2022. PMID: 36111016 Free PMC article.
• Melatonin alleviates pyroptosis by regulating the SIRT3/FOXO3α/ROS axis and interacting with apoptosis in Atherosclerosis progression.
  Cong L, Liu X, Bai Y, Qin Q, Zhao L, Shi Y, Bai Y, Guo Z. Cong L, et al. Biol Res. 2023 Dec 2;56(1):62. doi: 10.1186/s40659-023-00479-6. Biol Res. 2023. PMID: 38041171 Free PMC article.
• Platelet-Derived S1P and Its Relevance for the Communication with Immune Cells in Multiple Human Diseases.
  Tolksdorf C, Moritz E, Wolf R, Meyer U, Marx S, Bien-Möller S, Garscha U, Jedlitschky G, Rauch BH. Tolksdorf C, et al. Int J Mol Sci. 2022 Sep 7;23(18):10278. doi: 10.3390/ijms231810278. Int J Mol Sci. 2022. PMID: 36142188 Free PMC article. Review.

References

1. 1. Ross R. Atherosclerosis—An inflammatory disease. N. Engl. J. Med. 1999;340:115–126. doi: 10.1056/NEJM199901143400207. - DOI - PubMed
2. 1. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–325. doi: 10.1038/nature10146. - DOI - PubMed
3. 1. Kanter J.E., Kramer F., Barnhart S., Averill M.M., Vivekanandan-Giri A., Vickery T., Li L.O., Becker L., Yuan W., Chait A., et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. USA. 2012;109:E715–E724. doi: 10.1073/pnas.1111600109. - DOI - PMC - PubMed
4. 1. Li J.J., Chen J.L. Inflammation may be a bridge connecting hypertension and atherosclerosis. Med. Hypotheses. 2005;64:925–929. doi: 10.1016/j.mehy.2004.10.016. - DOI - PubMed
5. 1. Tabas I., Garcia-Cardena G., Owens G.K. Recent insights into the cellular biology of atherosclerosis. J. Cell Biol. 2015;209:13–22. doi: 10.1083/jcb.201412052. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • MDPI
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information